TRANSLATIONAL HEALTH SCIENCE AND TECHNOLOGY INSTITUTE (THSTI) is an autonomous Institute of the Department of Biotechnology under the Ministry of Science and Technology, Govt. of India. THSTI has been developed as a part of the interdisciplinary Health biotech Science cluster to be located at Faridabad which is a part of the National Capital Region. The Institute is being mentored by globally recognized National Institute of Immunology (NII) and the Harvard-MIT Division of Health Science and Technology (HM-HST). THSTI is designed to be a dynamic and interactive organization with a mission to conduct innovative translational research and develop research collaborations across disciplines and professions to accelerate the development of concepts into tangible products to improve human health. The other members of the cluster include The Regional Centre of Biotechnology (RCB) under the aegis of UNESCO and the NII with which the THSTI will have a seamless collaboration to achieve the interdisciplinary expertise. The cluster will have access to the state of the art experimental animal facility and the platform technology center for the sophisticated instrumentation. The permanent laboratories of the centre will come up in Faridabad within 3 years. The interim laboratories of the centre are functioning from Gurgaon in the South of Delhi area with adequate housing, transportation and schooling facilities. Campus housing may be available when the centre moves to Faridabad.

Vaccine and Infectious Disease Research Center (VIDRC) has been set up as a mission center of the THSTI to study infectious disease and pathogens with the aim to generate translational knowledge for developing prophylactic and therapeutic measures against diseases prevalent in India.

Post: JRF, SRF, RA

[adsense:336x280:8701650588]

Lupin Pharmaceuticals, Inc. is the U.S. wholly owned subsidiary of Lupin Limited, which is among the top six pharmaceutical companies in India. Through our sales and marketing headquarters in Baltimore, MD, Lupin Pharmaceuticals, Inc. is dedicated to delivering high-quality, branded and generic medications trusted by healthcare professionals and patients across geographies.

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

About Authors:  RAJESH Z. MUJORIYA,
M.PHARM.(PHARMACEUTICS)
Assistant Professor,
sardar patel college of technology, balaghat M.P.

ABSTRACT
Pantoprazole sodium is proton pump inhibitor and used as an antiulcer agent.  The study was undertaken with an aim to formulate pantoprazole sodium enteric coated pellets.
Before going to develop the formulation a detail product literature review was carried out to know about the MUPS and type of dosage form available in market. The present study was focused to formulate delayed release capsule by MUPS Technique.
Average pellets size was determined by sieve analysis and found to be 1680-1200 microns (ASTM sieve no. 12-16). Sieve analysis was the essential step before coating. Because uniform sized pellets undergo effective coating. The result indicates a effective enteric coating and delay the drug release, with 32% acryl ezee solution, is possible. The formulation developed can further be worked on. For identifying a best formulation for delayed release pellets of pantoprazole sodium.

The University of Kashmir is spread over 263 acres of lush green land with three adjacent campuses of exquisite beauty, Amar Singh Bagh, Naseem Bagh and Mirza Bagh. Amar Singh Bagh is located on the bank of the Dal having on its other three sides a background of mountainous amphitheatre rising to a great height above its crystal clear water.

Swami Vivekanand Subharti University is a University under section 2(f) of the University Grant Commission (U.G.C.) Act, 1956 having been setup under the Swami Vivekanand Subharti Vishwavidhaylaya Uttar Pradesh Adhiniyam,2008(U.P.Act No.29 of 2008)as passed by Uttar Pradesh legislature and and assented by the Hon'ble Governer Of Uttar Pradesh in September 2008.

Porteck Corporation continues to provide the highest quality professional service and software to its clients. Porteck offers Software as a Service to US healthcare providers, payers, and healthcare technology companies. Our Software based business process solutions are designed to increase process efficiencies, improve quality, and significantly reduce operating expenses for our clients.

Established in the year 1978 as an exclusive facility for Small Volume Parenterals (SVPs), Gland Pharma has developed into a progressive and quality conscious organization serving the pharmaceutical needs of diverse markets across the globe.
The Company has world-class & world-scale facilities for injectables set up in collaboration with Vetter Group, Germany. The collaboration with Vetter provides Gland Pharma a technological edge in injectables and specifically in Pre Filled Syringes.

Colgate's leadership position in the global marketplace is directly linked to the skill of our employees. Practical learning and professional growth are critical to our continued success. We invest generously in the training and education of Colgate people.

About Authors: Kollu Varuni, B.pharm
Vathsalya college of pharmacy,
J.N.T.U University

Introduction:
Tamsulosin is a selective, potent and competitive a  1 – adrenoreceptor antagonist and has a greater affinity for these receptors, predominantly present in the human prostate. Literature survey reveals that several methods like HPLC,HPLC-MS and LC-MS were reported for the estimation of Tamsulosin hydrochloride in combination with other drugs as well as in biological fluids [1- 3]

Fortis Hospitals, Bangalore, Kolkata, Mulund, Kalyan: Imagine a hospital functioning with you as its centre point. Compassion and warmth along with medical care par excellence. Imagine a hospital that understands the difference between being well and well-being. These, and much more, are wishes brought to reality by a revolution called Fortis Healthcare Network.

Indian Institute of Technology Roorkee, Roorkee invites the applications on the prescribed form for the following posts as per details given against each. The application form and general conditions may be obtained from Superintendent, Establishment ‘B’ Section, IIT Roorkee.

A walk-in- interview will be conducted on April 04, 2011 at 11:00 AM in the department of Biotechnology, Indian Institute of Technology, Roorkee to select candidates for the following positions as per details given below under the DST sponsored research scheme, "Isolation and characterization of flavono

Priyadarshini college of pharmaceutical sciences was established in 2005. The college is located by the side of four lane track of Hyderabad – Warangal, 7 KM from Uppal X road and 2 km from Singapore Township. The campus lies close to the upcoming Raheja IT park. It is connected by road, rail and air to all parts of the country. Hyderabad enjoys a pleasant climate throughout the year.

United Biotech has been a trend setter of new standards and is among the fastest growing companies in the Indian pharmaceutical Industry. In a span of 12 years it has established an enviable reputation and track record for adopting latest manufacturing technologies, introducing world-class quality of products, ground breaking Research & Development efforts in association with its foreign counterparts and for setting new standards of customer service.

About Authors: Varun Raj Vemula*¹, Swathi Thakkalapally², Chaitanya Kumari Bairi^3
1DepartmentofPharmaceutical Chemistry, Vikas College of Pharmacy, Jangaon, Warangal. Affiliated to Kakatiya University.
²Department of Pharmaceutics, Care College of Pharmacy, Warangal. Affiliated to Kakatiya University.
³Department of Pharmaceutics, TallaPadmavathi College of pharmacy, Warangal. Affiliated to Kakatiya University.

Abstract:
Carrier erythrocytes have been evaluated in thousands of drug administration in humans proving safety and efficacy of the treatments. Carrier erythrocytes, resealed erythrocytes loaded by a drug or other therapeutic agents, have been exploited extensively in recent years for both temporally and spatially controlled delivery of a wide variety of drugs and other bioactive agents owing to their remarkable degree of biocompatibility, biodegradability and a series of other potential advantages. Biopharmaceuticals, therapeutically significant peptides and proteins, nucleic acid-based biologicals, antigens and vaccines, are among the recently focused pharmaceuticals for being delivered using carrier erythrocytes. In this review article, the potential applications of erythrocytes in drug delivery have been reviewed with a particular stress on the studies and laboratory experiences on successful erythrocyte loading and characterization of the different classes of biopharmaceuticals.

[adsense:336x280:8701650588]

About Authors: * Ryali. Jithendra, Dinesh Kumar. Pandurangan, Bandaru. Sowjanya¹, Vijayaraj Kumar. Perumal²
1Department of Biotechnology, Acharya Nagarjuna University, Guntur – 522 510, India,
*1-Department of Pharmaceutics, Rahul Institute of Pharmaceutical Science & Research, Chirala-523157, Andhra Pradesh, India.
2-School of Pharmacy, University College Sadaya International,Kuala Lumpur, Malaysia.

ABSTRACT:
Pharmacovigilance is an important and integral part of clinical research. Pharmacovigilance is “defined as the pharmacological science relating to the detection, assessment, understanding and prevention of adverse effects, particularly long term and short term adverse effects of medicines. This addresses what exactly is pharmacovigilance?  What do we know of its benefits and risks, challenges and the future hold for pharmacovigilance in Indian medicine. Here the main focus on the aims and role of pharmacovigilance in medicines regulation and their Partners. This article describes and discusses the National programme of pharmacovigilance and centre in India. There role in collecting the reports ADRs of medicines. Further effectiveness and risk assessments of therapies are been discussed. The important role played by health care professional, pharmaceutical industries, media, and programmes carried by WHO. Finally the conclusion describes the major challenges and achievements for the future pharmacovigilance programme.